Expensify Inc (NAS:EXFY)
$ 2.37 -0.055 (-2.26%) Market Cap: 216.11 Mil Enterprise Value: 155.73 Mil PE Ratio: 0 PB Ratio: 1.62 GF Score: 60/100

Q2 2026 Expensify Inc Earnings Call Transcript

Aug 6, 2026 / 09:00 PM GMT
Release Date Price: $1.98 (-1.98%)

Key Points

Positve
  • Expensify Inc (EXFY) significantly improved profitability, with GAAP net loss narrowing to $3.9 million from $8.8 million year-over-year and non-GAAP net income turning positive at $3.4 million.
  • The company generated strong cash flow, with Q2 free cash flow of $6.4 million, up 162% from the previous quarter, leading to a raised full-year 2026 free cash flow guidance to $12-$14 million.
  • New Expensify, the company's AI-driven product, is showing rapid growth, with net new revenue from customers who never used Classic growing over 250% year-over-year to more than $10 million in ARR.
  • Expensify Inc (EXFY) demonstrated commitment to shareholders by repurchasing approximately 6.8 million shares of Class A common stock in Q2, representing a roughly 7% reduction in shares outstanding.
  • The company launched over 30 new features and enhancements in Q2, including advanced AI capabilities like agent rules, custom agents, and the Expensify MCP, which was recognized with the 'Expense Management Platform of the Year' award.
  • Card interchange revenue grew 12% year-over-year to $5.9 million, indicating continued scaling of the card program despite a marketing push for 'bring your own card'.
Negative
  • Expensify Inc (EXFY) continues to experience top-line pressure, with total revenue declining year-over-year to $33.9 million.
  • Average paid members decreased to 640,000 in Q2, and further declined to 634,000 in July 2026, reflecting ongoing churn in the Classic customer base.
  • The company's modified Dutch auction tender offer was substantially undersubscribed, indicating weak shareholder demand to sell at the offered price, despite a premium.
  • The Classic to New Expensify migration is in its 'long tail,' and the company admits it is unclear whether New Expensify's growth will outpace Classic's churn, creating uncertainty about the timeline for returning to overall growth.
  • AI spend is scaling and the company is actively trying to cut it back, suggesting rising costs in this area that could pressure future profitability.
  • The company's story remains complex and confusing to investors, as it combines a fast-growing startup (New Expensify) with a cash-flow-positive but shrinking legacy business (Classic), making it difficult to forecast overall performance.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

EXFY.OQ - Expensify, Inc.
Q2 2026 Expensify Inc Earnings Call
Aug 06, 2026 / 09:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hello, and thank you for joining us for Expensify's Q2 2026 earnings call. My name is Nikki, and I'm going to start off with the legal disclosure, and then I'll hand things off to Ryan Schafer, our CFO, and David Barrett, our founder and CEO. Please note that all the information presented on today's call is unaudited, and during the course of this call, management may make forward-looking statements within the meaning of the federal securities laws. These statements are based on management's current expectations and beliefs and involve risks and uncertainties. That could cause actual results to differ materially from those described in these forward-looking statements. Forward-looking statements in the earnings release that we issued today along
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot